Prime Medicine, Inc. Common Stock (PRME) revenue is $1.2M
Prime Medicine, Inc. Common Stock (PRME) revenue is $1.2M as of 2025-09-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full PRME research page for quote, filings, and the rest of the model. This satellite exists so “Prime Medicine, Inc. Common Stock revenue” can rank with the actual number, then send you to /stock/prme.